Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Scientific Reports|May 2, 2025
A model workflow for microfluidic enrichment and genetic analysis of circulating melanoma cellsCristina Poggiana, Alessandro Francesco Piazza, Cristina Catoni, et al.
Frontiers in Oncology|May 1, 2020
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma PatientsMarco Rastrelli, Paolo Del Fiore, Alessandra Buja, et al.
Life (Basel, Switzerland)|May 28, 2022
Altitude Effect on Cutaneous Melanoma Epidemiology in the Veneto Region (Northern Italy): A Pilot StudyPaolo Del Fiore, Irene Russo, Alessandro Dal Monico, et al.
International Journal of Molecular Sciences|April 30, 2021
The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI)Lisa Elefanti, Carolina Zamuner, Paolo Del Fiore, et al.
Frontiers in Oncology|January 7, 2022
The Role of Electrochemotherapy in the Cutaneous and Subcutaneous Metastases From Breast Cancer: Analysis of Predictive Factors to Treatment From an Italian Cohort of PatientsFrancesco Russano, Paolo Del Fiore, Claudia Di Prata, et al.
Journal of Medical Screening|November 13, 2019
Cost-effectiveness of a melanoma screening programme using whole disease modellingAlessandra Buja, Michele Rivera, Giovanni Girardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2020
Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic SarcomaMaria Assunta Piano, Antonella Brunello, Rocco Cappellesso, et al.
Cancers|February 24, 2024
Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case SeriesIrene Russo, Dario Marino, Claudia Cozzolino, et al.
BMC Cancer|June 6, 2022
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086)Saveria Tropea, Paolo Del Fiore, Andrea Maurichi, et al.
Frontiers in Medicine|August 24, 2023
Indicators of clinical performance in monitoring soft tissue sarcoma management: a population-based perspectiveMassimo Rugge, Alessandra Buja, Saveria Tropea, et al.
Pageof 10